COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review

BACKGROUND: The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well understood. METHODS: To address this question...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Jessica M., Faruqi, Aiman J., Sullivan, James K., Calabrese, Cassandra, Calabrese, Leonard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150936/
https://www.ncbi.nlm.nih.gov/pubmed/34056149
http://dx.doi.org/10.20411/pai.v6i1.435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150936/
https://www.ncbi.nlm.nih.gov/pubmed/34056149
http://dx.doi.org/10.20411/pai.v6i1.435

Ejemplares similares